Histaminergic Receptors Modulate Spinal Cord Injury-Induced Neuronal Nitric Oxide Synthase Upregulation and Cord Pathology: New Roles of Nanowired Drug Delivery for Neuroprotection-Reference-Cited by-同舟云学术

Histaminergic Receptors Modulate Spinal Cord Injury-Induced Neuronal Nitric Oxide Synthase Upregulation and Cord Pathology: New Roles of Nanowired Drug Delivery for Neuroprotection

Published:2017 Issue: Volume: Page:65-98
ISSN:0074-7742
Container-title:International Review of Neurobiology
language:
Short-container-title:

Author:

Sharma Hari S.,Patnaik Ranjana,Muresanu Dafin F.,Lafuente José V.,Ozkizilcik Asya,Tian Z. Ryan,Nozari Ala,Sharma Aruna

Publisher

Elsevier

Reference73 articles.

1. A new antioxidant compound H-290/51 attenuates nitric oxide synthase and heme oxygenase expression following hyperthermic brain injury. An experimental study using immunohistochemistry in the rat;Alm;Amino Acids,2000

2. Histochemical localization of nitric oxide neurons in the hypothalamus: Association with gonadotropin-releasing hormone neurons and co-localization with N-methyl-d-aspartate receptors;Bhat;Neuroendocrinology,1995

3. Co-localization of NOS and NMDA receptor in esophageal premotor neurons of the rat;Broussard;Neuroreport,1995

4. Involvement of nitric oxide in central histaminergic stimulation of the hypothalamic-pituitary-adrenal axis;Bugajski;Journal of Physiology and Pharmacology,2000

5. Traumatic brain injury: Oxidative stress and neuroprotection;Cornelius;Antioxidants & Redox Signaling,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury;Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B;2023

2. Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha;Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-Morbidity Factors Part B;2023

3. Drug screening in zebrafish larvae reveals inflammation-related modulators of secondary damage after spinal cord injury in mice;Theranostics;2023

4. Co-Administration of Nanowired Monoclonal Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha Together with Antioxidant H-290/51 Reduces SiO2 Nanoparticles-Induced Exacerbation of Pathophysiology of Spinal Cord Trauma;Advances in Neurobiology;2023

5. Bioactive hybrid nanowires for drug delivery;Hybrid Nanomaterials for Drug Delivery;2022